Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 1.00 |
| ▸ | F10 | P00742 | 6/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.53 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.52 |
| ▸ | CDC25B | P30305 | 1/20 | 0.52 |
| ▸ | SELP | P16109 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24834667 | 1.00 | HSD11B1 (1.00) | HSD11B1F10PTPN1PTPN2CDC25B | |
| SCHEMBL4733774 | 1.00 | HSD11B1 (1.00) | HSD11B1F10PTPN1PTPN2CDC25B | |
| SCHEMBL19522314 | 1.00 | HSD11B1 (1.00) | HSD11B1F10PTPN1PTPN2CDC25B | |
| SCHEMBL14704498 | 1.00 | HSD11B1 (1.00) | HSD11B1F10PTPN1PTPN2CDC25B | |
| SCHEMBL16491619 | 1.00 | HSD11B1 (1.00) | HSD11B1F10PTPN1PTPN2CDC25B | |
| SCHEMBL5043912 | 0.84 | HSD11B1 (0.81) | HSD11B1F10PTPN1MEN1KMT2A | |
| SCHEMBL5043911 | 0.84 | HSD11B1 (0.81) | HSD11B1F10PTPN1MEN1KMT2A | |
| Annosquamosin B SCHEMBL31497491 | 0.84 | HSD11B1 (0.81) | HSD11B1F10PTPN1PTPN2CDC25B | |
| SCHEMBL13401529 | 0.79 | SELP (0.66) | HSD11B1F10PTPN1PTPN2CDC25B | |
| SCHEMBL16489095 | 0.79 | HSD11B1 (0.68) | HSD11B1F10PTPN1PTPN2CDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9801918-B2 | Methods of treatment using extracts of Anisomeles heyneana | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-10-31 | — | — | US | disclosed |
| US-20160271196-A1 | Compounds from Anisomeles Heyneana | COUNCIL SCIENT IND RES (IN) | 2016-09-22 | — | — | US | disclosed |
| US-20150051277-A1 | Compounds from Anisomeles Heyneana | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-02-19 | — | — | US | disclosed |
| WO-2013021260-A2 | COMPOUNDS FROM ANISOMELES HEYNEANA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGISTRATION OF SOCIETIES ACT (ACT XXI OF 1860) (IN) | 2013-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051277-A1 | Compounds from Anisomeles Heyneana | MCL1, ANXA3, IKZF3 | HSD11B1 1584/4885F10 3342/4885PTPN1 3753/4885 |
| US-20160271196-A1 | Compounds from Anisomeles Heyneana | MCL1, IKZF3, ANXA3 | HSD11B1 1561/4885F10 3347/4885PTPN1 3751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.